Total Payments
$1,965
2024 Payments
$13.61
Companies
15
Transactions
151
Medicare Patients
4,529
Medicare Billing
$572,375
Payment Breakdown by Category
Food & Beverage$1,965 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,965 | 151 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $505.05 | 49 | $0 (2020) |
| Daiichi Sankyo Inc. | $360.00 | 22 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $276.80 | 24 | $0 (2018) |
| Purdue Pharma L.P. | $192.05 | 18 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $135.88 | 12 | $0 (2017) |
| Nevro Corp. | $78.07 | 3 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $70.83 | 6 | $0 (2018) |
| Lundbeck LLC | $69.21 | 4 | $0 (2019) |
| SI-BONE, Inc. | $65.96 | 2 | $0 (2018) |
| Depomed, Inc. | $59.55 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.61 | 1 | Abbott Laboratories ($13.61) |
| 2020 | $47.60 | 2 | Nevro Corp. ($24.06) |
| 2019 | $17.46 | 1 | Lundbeck LLC ($17.46) |
| 2018 | $847.69 | 69 | PFIZER INC. ($309.05) |
| 2017 | $1,039 | 78 | Daiichi Sankyo Inc. ($324.27) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Diabetes Care | ||||||
| 02/03/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/02/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.46 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2018 | Shionogi Inc | Symproic (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Gastroenterology | ||||||
| 12/18/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/27/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/19/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Lower GI | ||||||
| 11/06/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/01/2018 | Shionogi Inc | Symproic (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Gastroenterology | ||||||
| 10/29/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/29/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: Lower GI | ||||||
| 10/18/2018 | PFIZER INC. | SUTENT (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 10/16/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/16/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/11/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Lower GI | ||||||
| 10/09/2018 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Addiction Therapy | ||||||
| 10/02/2018 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Lower GI | ||||||
| 08/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Lower GI | ||||||
| 08/27/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: Lower GI | ||||||
| 08/20/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/17/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Lower GI | ||||||
| 08/07/2018 | BioDelivery Sciences International, Inc. | BUNAVAIL 2.1 mg 30-count box (Drug), BUNAVAIL 2.1 mg single pouch, BUNAVAIL 4.2 mg 30-count box | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Addiction Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 853 | 1,484 | $384,974 | $112,219 |
| 2022 | 12 | 1,026 | 1,926 | $493,925 | $145,589 |
| 2021 | 14 | 1,161 | 2,070 | $467,247 | $160,056 |
| 2020 | 17 | 1,489 | 2,312 | $524,043 | $154,511 |
Total Patients
4,529
Total Services
7,792
Medicare Billing
$572,375
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 402 | $84,184 | $27,737 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 129 | 366 | $74,100 | $24,772 | 33.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 53 | 56 | $50,147 | $12,292 | 24.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 53 | 72 | $28,311 | $6,383 | 22.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 41 | 65 | $21,480 | $5,703 | 26.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 35 | 46 | $20,333 | $4,763 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 86 | $13,426 | $4,051 | 30.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 52 | 55 | $13,198 | $3,799 | 28.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 30 | 35 | $16,400 | $3,578 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,845 | $3,258 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 43 | 61 | $9,031 | $2,921 | 32.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 33 | 44 | $9,258 | $2,652 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $10,157 | $2,295 | 22.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 30 | 35 | $7,589 | $2,064 | 27.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 15 | 18 | $3,628 | $1,336 | 36.8% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 14 | 17 | $3,428 | $1,323 | 38.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 13 | 14 | $3,181 | $1,136 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,642 | $846.43 | 32.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 14 | 20 | $1,874 | $707.40 | 37.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 19 | $1,761 | $601.29 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 171 | 534 | $109,275 | $36,697 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 448 | $91,979 | $31,307 | 34.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 65 | 105 | $46,855 | $10,606 | 22.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 39 | 42 | $37,017 | $9,459 | 25.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 48 | 79 | $27,428 | $7,141 | 26.0% |
About Dr. Muhammad Khan, MD
Dr. Muhammad Khan, MD is a Pain Medicine healthcare provider based in Sanford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881689065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Khan, MD has received a total of $1,965 in payments from pharmaceutical and medical device companies, with $13.61 received in 2024. These payments were reported across 151 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,965).
As a Medicare-enrolled provider, Khan has provided services to 4,529 Medicare beneficiaries, totaling 7,792 services with total Medicare billing of $572,375. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Sanford, ME
- Active Since 09/14/2005
- Last Updated 04/02/2014
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881689065
Products in Payments
- Amitiza (Drug) $412.68
- LYRICA (Drug) $350.03
- Movantik (Drug) $230.43
- Morphabond ER (Drug) $129.57
- Senza Spinal Cord Stimulation System (Device) $78.07
- OXYCONTIN (Drug) $70.14
- iFuse Implant (Device) $65.96
- Xtampza ER (Drug) $59.90
- Nucynta (Drug) $59.55
- CHANTIX (Drug) $57.80
- BUTRANS (Drug) $49.93
- HYSINGLA ER (Drug) $47.03
- SUTENT (Drug) $45.41
- Symproic (Drug) $42.24
- ELIQUIS (Drug) $37.98
- TRINTELLIX (Drug) $29.79
- BUNAVAIL 2.1 mg 30-count box (Drug) $29.31
- SCS IPGs (Device) $28.00
- RELISTOR ORAL (Drug) $25.20
- REXULTI (Drug) $21.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.